Menu
Seasoned entrepreneurs and healthcare innovators
Mark Rainosek
Founder and Chief Executive Officer
Over the past 25 years, Mark Rainosek has founded and developed multiple early-stage innovator companies, raised millions of dollars of strategic and venture capital, and has successfully exited three of these companies through acquisition to public technology companies.
Mark Rainosek
Founder and Chief Executive Officer
Over the past 25 years, Mark Rainosek has founded and developed multiple early-stage innovator companies, raised millions of dollars of strategic and venture capital, and has successfully exited three of these companies through acquisition to public technology companies.
Jay Brennan, JD MBA
Founder and Chief Operating Office
Over the past 25 years, Mark Rainosek has founded and developed multiple early-stage innovator companies, raised millions of dollars of strategic and venture capital, and has successfully exited three of these companies through acquisition to public technology companies.
Jay Brennan, JD MBA
Founder and Chief Operating Office
Over the past 25 years, Mark Rainosek has founded and developed multiple early-stage innovator companies, raised millions of dollars of strategic and venture capital, and has successfully exited three of these companies through acquisition to public technology companies.
David Heenan
Principal
David founded Aces Health 2015 in order to address these challenges by leveraging mobile technology and artificial intelligence. Aces Health, now Dedo.ai, was acquired by a San Francisco-based Venture Studio in 2018. Until recently, David managed BrightEdge, the philanthropic impact fund of the American Cancer Society, investing in companies working on novel and innovative therapies, devices, and technologies for cancer treatment.
David Heenan
Principal
David founded Aces Health 2015 in order to address these challenges by leveraging mobile technology and artificial intelligence. Aces Health, now Dedo.ai, was acquired by a San Francisco-based Venture Studio in 2018. Until recently, David managed BrightEdge, the philanthropic impact fund of the American Cancer Society, investing in companies working on novel and innovative therapies, devices, and technologies for cancer treatment.
James Bauler
Venture Director
James started his career selling securities with First Trust. He went on to build and manage teams in diverse and complex settings across Asia, the Middle East, and Africa as a Country Representative for Samaritan’s Purse. Prior to joining Cone Health Ventures / Prinnovo, James ran Corporate Development for FLAG Therapeutics, a small molecule drug development company with a focus on rare and aggressive cancers. James brings deep healthcare operational and business development experience having driven successful deals and financings with VC, Strategics, and non-dilutive governmental capital.
James Bauler
Venture Director
James started his career selling securities with First Trust. He went on to build and manage teams in diverse and complex settings across Asia, the Middle East, and Africa as a Country Representative for Samaritan’s Purse. Prior to joining Cone Health Ventures / Prinnovo, James ran Corporate Development for FLAG Therapeutics, a small molecule drug development company with a focus on rare and aggressive cancers. James brings deep healthcare operational and business development experience having driven successful deals and financings with VC, Strategics, and non-dilutive governmental capital.
We establish, staff, and manage health venture offices for mid-sized health systems.
Follow Us
Copyright © 2023 prinnovo | All Rights Reserved